Ausun Pharm(SH:603229) Xin Lang Cai Jing·2025-10-31 02:32Core Insights - Aoshang Pharmaceutical (603229.SH) reported its Q3 2025 results on October 31, 2025, indicating a total of 53.1 million shares held by six institutional investors, representing 6.40% of the company's total equity [1] Institutional Holdings - The total institutional holding decreased by 1.54 percentage points compared to the previous quarter [1] - The institutional investors include Jiaxing Aoshang Equity Investment Management Partnership, Shanghai Duxi Bingtai Private Fund Management Co., Ltd., Taizhou Jinkong Asset Management Co., Ltd., and others [1] Public Fund and Foreign Investment - There were 68 public funds that did not disclose holdings in this period, including several ETFs focused on the CSI 1000 index [1] - Foreign investment saw a slight increase with one foreign fund, Hong Kong Central Clearing Limited, increasing its holdings [1]